about
T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progressionTargeting the UPS as therapy in multiple myeloma.Sensitivity analysis of dynamic biological systems with time-delaysPhotodynamic therapy and anti-tumour immunity.Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.Inhibiting NF-κB activation by small molecules as a therapeutic strategy.Novel targets for prostate cancer chemoprevention.Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanismsInhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.Isothiocyanates inhibit proteasome activity and proliferation of multiple myeloma cells.Anti-arthritis effects of (E)-2,4-bis(p-hydroxyphenyl)-2-butenal are mediated by inhibition of the STAT3 pathwayInduction of cancer cell death by isoflavone: the role of multiple signaling pathways.Chloroform Fraction of Centratherum anthelminticum (L.) Seed Inhibits Tumor Necrosis Factor Alpha and Exhibits Pleotropic Bioactivities: Inhibitory Role in Human Tumor Cells.Mining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach.Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?Mechanisms and therapeutic implications of cell death induction by indole compounds.Green tea and bone metabolism.Cellular signaling perturbation by natural products.Co-culture of hepatoma cells with hepatocytic precursor (stem-like) cells inhibits tumor cell growth and invasion by downregulating Akt/NF-κB expression.Anti-inflammatory and arthritic effects of thiacremonone, a novel sulfur compound isolated from garlic via inhibition of NF-kappaB.Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors.Knockdown of NF-κB p65 subunit expression suppresses growth of nude mouse lung tumour cell xenografts by inhibition of Bcl-2 apoptotic pathway.Ponapensin, a cyclopenta[bc]benzopyran with potent NF-kappaB inhibitory activity from Aglaia ponapensis.Quantitative chemiluminescent immunoassay for NF-kappaB-DNA binding activity.Tea polyphenol epigallocatechin 3-gallate impedes the anti-apoptotic effects of low-grade repetitive stress through inhibition of Akt and NFkappaB survival pathways.Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers.Targeting IκappaB kinases for cancer therapy.
P2860
Q27335110-7CA4D10D-3467-42D3-A990-07ED78BDC499Q28389404-F3033D15-6055-4FFE-BF43-1D75860447FCQ33384287-BE90E1A9-D9AA-4F92-AA0E-F0435AA16091Q33755571-325EA9E3-E3BC-4D21-B18E-E06B47172B34Q34105703-261D57B0-D655-4D12-8A7D-208AC56D7F18Q34120334-3313FA11-7A52-4C9A-A52B-DCF77BB3C824Q34205025-443AF233-CFAE-4C65-ACA3-FAD42763B118Q34289576-9294CE83-F893-40A3-AC81-A65BEA61EB8EQ34343736-3D00F3BB-522A-4896-AC7E-428005C82CD3Q34352092-F32207B0-2CC4-482D-8D63-258D97C52F08Q34520431-451B09D8-96D0-4C48-8942-89594A75B916Q34570822-35036D09-10C3-4FC8-894F-7EA88A58B414Q35628160-B1C0FF33-32BC-47D0-8594-C30819F294E8Q35830073-DAFAA609-1CA0-4EF3-BA75-87EB3908757EQ36285296-068363D2-5C45-48D5-9DF0-8AB234B1449EQ36945706-F5366964-58B5-46D4-8DA8-8259B7D5D09EQ37137367-AA4E285A-6E1F-4CAF-8CD2-7138965A1353Q37368071-C4C18EB7-EB7F-4AD6-9148-73531EEA8300Q37373545-5927E0C8-E496-4356-89E5-825462390FE7Q37407300-B0B8B4F9-6CB2-4140-9D42-66701A385D8BQ37454055-1F864B5C-16C5-48D4-B778-601B177D97C6Q38028535-4A3DAF20-2A99-4406-84C5-6646DAAC3FC6Q38852588-97E3BD77-5913-4CEA-B399-17E0DD47B432Q40217301-C0CB425C-DC30-4FFE-89DD-8660379CA263Q40442147-920DC492-6769-4DE6-80B7-74EC5794EDA1Q46866939-64F48328-1A8F-4DC4-ABB9-E3FD9BC55B2DQ47708275-CEF2B1D6-0E62-4856-8E0F-7B35ABB83597Q52372117-E916BE00-5964-4737-9344-BA7279D67161
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
NF-kappa B: arresting a major culprit in cancer.
@ast
NF-kappa B: arresting a major culprit in cancer.
@en
NF-kappa B: arresting a major culprit in cancer.
@nl
type
label
NF-kappa B: arresting a major culprit in cancer.
@ast
NF-kappa B: arresting a major culprit in cancer.
@en
NF-kappa B: arresting a major culprit in cancer.
@nl
prefLabel
NF-kappa B: arresting a major culprit in cancer.
@ast
NF-kappa B: arresting a major culprit in cancer.
@en
NF-kappa B: arresting a major culprit in cancer.
@nl
P1433
P1476
NF-kappa B: arresting a major culprit in cancer.
@en
P2093
Burkhard Haefner
P304
P356
10.1016/S1359-6446(02)02309-7
P577
2002-06-01T00:00:00Z